Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹19,506.00
36.00 (0.18%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹25.03K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
68.9
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹11,500+69.6%
52W High₹20,089-2.9%
Current Price
₹19,506.00
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹15,604.80
Upper Circuit₹23,407.20
Reference Price
₹19,506.00
Investment Checklist
Ascending Channel on 1D — target ₹20091.18
Bull Flag on 1D — target ₹21117.0
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Volume divergence: Bearish (price up, volume down)
RSI at 77.3 — overbought, pullback risk
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
83%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
18360.01
EMA50
17252.29
EMA200
15600.22
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows7
Lower Highs4
Lower Lows2
Support & Resistance Levels
Resistance (Above)
₹19747.00
Support (Below)
₹18305.00
₹17602.00
₹16776.00
₹16496.50
₹15924.67
Volume Analysis
TrendSTABLE
Change-2.90%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹19310.94
3% Risk₹18920.82
5% Risk₹18530.70
7% Risk (Custom)
₹18140.58Technical Levels
1x ATR (Volatility)₹18898.84
2x ATR (Swing)₹18291.68
3x ATR (Trend)₹17684.52
Immediate Support₹18305.00
Moving Averages
EMA 9 (Short-term)₹18953.63
EMA 20 (Medium-term)₹18360.01
EMA 50 (Trend)₹17252.29
EMA 200 (Long-term)₹15600.22
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹285.9 Cr | ₹292.8 Cr | ₹514.3 Cr | ₹439.7 Cr |
| Net Profit | ₹27.8 Cr | ₹13.9 Cr | ₹96.9 Cr | ₹40.6 Cr |
| EPS | — | ₹10.83 | ₹75.49 | ₹31.62 |
| Operating Profit | ₹56 Cr | ₹42.3 Cr | ₹157.3 Cr | ₹85.2 Cr |
ROE
17.06%
ROCE
20.94%
Debt/Equity
0.10
Current Ratio
2.45
OPM
19.37%
NPM
9.23%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Neuland Laboratories Limited | ₹19,506.00 | -0.18% | 68.9 | ₹25.03K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 18 Jul 2025 | Dividend - Rs 12 Per Share | DIVIDEND |
| 12 Jul 2024 | Annual General Meeting/Dividend - Rs 14 Per Share | AGM |
| 11 Jul 2023 | Annual General Meeting/Dividend - Rs 10 Per Share | AGM |
| 14 Jul 2022 | Annual General Meeting/Dividend - Rs 5 Per Share | AGM |
| 29 Jun 2021 | Annual General Meeting/Dividend - Rs 3 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for NEULANDLAB
View All
positive
Business Standard - Markets 1d ago
Mukul Agrawal portfolio: Neuland zooms 75% from March low; hits record high
Share price of Neuland Laboratories rallied 6 per cent to hit a record high of ₹20,072 on the BSE in Thursday's intra-day, after a gap of eight months.
BSEMOLOWVOLNEULANDLABFinancial ServicesHealthcare
positive
ET Markets - Stocks 59d ago
Neuland Laboratories shares rally 7% as profit jumps seven-fold and revenue doubles in Q4
Neuland Laboratories shares saw a significant jump following a strong Q4 performance. The company reported a massive increase in profit and revenue year-on-year. This robust financial result was driven by strong business momentum across key segments. The company is also investing in future growth through strategic initiatives.
FELFELDVRJMFINANCILMOGSECMOMENTUMNEULANDLABConsumer ServicesFinancial Services
positive
CNBC TV18 - Markets 59d ago
Neuland Laboratories shares in focus after a strong Q4 but Co warns of 'lumpy' numbers
Neuland Labs provides active pharmaceutical ingredients (APIs), complex intermediates, custom manufacturing solutions. The stock has risen over 18% in the last one month.
FOCUSNEULANDLABConsumer DurablesHealthcare